SWOG clinical trial number
S1912CD

A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)

Open
Phase
Accrual
98%
Abbreviated Title
CREDIT
Status Notes
This study will be permanently closed to new patient and caregiver accrual, effective December 16, 2024, at 12:00 p.m. Pacific Time.
Activated
07/26/2021
Participants
ALL NCI Community Oncology Research Program (NCORP) Affiliates and Subaffiliates

Research committees

Cancer Care Delivery

Eligibility Criteria Expand/Collapse

Please see Section 5.0 of the S1912CD protocol.

Publication Information Expand/Collapse

2023

Assessment of Financial Screening and Navigation Capabilities at NCI Community Oncology Clinics

A Bell-Brown;K Watabayashi;D Delaney;R Carlos;S Langer;J Unger;R Vaidya;A Darke;D Hershman;S Ramsey;V Shankaran JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055

PMid: PMID37561111 | PMC number: PMC10471524

Reports & Approvals

Trial Locations

Other Clinical Trials

SWOG Clinical Trial Number
S2108CD

A Cluster Randomized Trial Comparing an Educationally Enhanced Genomic Tumor Board (eGTB) Intervention to Usual Practice to Increase Evidence-Based Genome Informed Therapy
Research Committee(s)
Cancer Care Delivery
Activated
08/22/2022
Accrual
100%
Open
Phase
SWOG Clinical Trial Number
S1912CD

A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)
Research Committee(s)
Cancer Care Delivery
Activated
07/26/2021
Accrual
98%
Open
Phase
SWOG Clinical Trial Number
S1703

Randomized trial comparing overall survival of patients monitored with serum tumor marker directed disease monitoring (STMDDM) versus usual care in patients with metastatic hormone receptor positive breast cancer
Research Committee(s)
Cancer Care Delivery
Breast Cancer
Activated
07/16/2018
Accrual
50%
Open
Phase